121 related articles for article (PubMed ID: 8519230)
1. [Measurement of prothrombin fragment F1+2 for monitoring the anticoagulant effect of phenprocoumon].
Bruhn HD; Zurborn KH
Dtsch Med Wochenschr; 1993 Jul; 118(26):967-70. PubMed ID: 8519230
[TBL] [Abstract][Full Text] [Related]
2. The use of prothrombin fragment F1+2 to monitor the effect of oral anticoagulation.
Bruhn HD; Zurborn KH
J Heart Valve Dis; 1995 Mar; 4(2):138-40. PubMed ID: 8556173
[TBL] [Abstract][Full Text] [Related]
3. Effects of the oral anticoagulant phenprocoumon on blood coagulation and thrombogenesis induced by rabbit aorta subendothelium exposed to flowing human blood: role of dose and shear rate.
Inauen W; Bombeli T; Baumgartner HR; Haeberli A; Straub PW
J Lab Clin Med; 1991 Sep; 118(3):280-8. PubMed ID: 1919300
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of Quick/INR values of whole capillary blood (CoaguChek Plus) and venous citrate plasma in patients with and without oral anticoagulation].
Burri S; Demarmels Biasiutti F; Lämmle B; Wuillemin WA
Schweiz Med Wochenschr; 1998 Oct; 128(44):1723-9. PubMed ID: 9846345
[TBL] [Abstract][Full Text] [Related]
5. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
6. Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation--considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment.
Tripodi A; Cattaneo M; Molteni A; Cesana BM; Mannucci PM
Thromb Haemost; 1998 Mar; 79(3):571-3. PubMed ID: 9531043
[TBL] [Abstract][Full Text] [Related]
7. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
Koefoed BG; Feddersen C; Gulløv AL; Petersen P
Thromb Haemost; 1997 May; 77(5):845-8. PubMed ID: 9184390
[TBL] [Abstract][Full Text] [Related]
8. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
[TBL] [Abstract][Full Text] [Related]
9. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.
Kyrle PA; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Speiser W; Weltermann A; Kaider A; Pabinger I; Lechner K; Eichinger S
Thromb Haemost; 1997 Nov; 78(5):1327-31. PubMed ID: 9408013
[TBL] [Abstract][Full Text] [Related]
10. Effect of different oral anticoagulant intensities on prothrombin fragment 1 + 2 in Thai patients with mechanical heart valve prostheses.
Tientadakul P; Opartkiattikul N; Sangtawesin W; Sakiyalak P
J Med Assoc Thai; 1997 Feb; 80(2):81-6. PubMed ID: 9078691
[TBL] [Abstract][Full Text] [Related]
11. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of plasma prothrombin fragment 1+2 in healthy donors and thrombotic diseases].
Kawai Y; Shiomi T; Ono H; Katagiri H; Uchida R; Sugisaki N; Watanabe K
Rinsho Byori; 1994 Jan; 42(1):57-62. PubMed ID: 8107284
[TBL] [Abstract][Full Text] [Related]
13. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
14. Multicentric evaluation of a new assay for prothrombin fragment F1+2 determination.
Bruhn HD; Conard J; Mannucci M; Monteagudo J; Pelzer H; Reverter JC; Samama M; Tripodi A; Wagner C
Thromb Haemost; 1992 Oct; 68(4):413-7. PubMed ID: 1448772
[TBL] [Abstract][Full Text] [Related]
15. [Value of molecular markers for administration of anticoagulant therapy after heart valve replacement].
Dahm M; Lotz J; Hafner G; Oelert H; Prellwitz W
Z Kardiol; 1998; 87 Suppl 4():42-5. PubMed ID: 9857466
[TBL] [Abstract][Full Text] [Related]
16. INR comparison between the CoaguChek Pro PT(N) and a standard laboratory method.
Khoschnewis S; Hannes FM; Tschopp M; Wuillemin WA
Thromb Res; 2004; 113(5):327-32. PubMed ID: 15183045
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of hypercoagulable state in patients with malignancies by using prothrombin fragment F1 + 2].
Nakagawa K; Tsuji H; Yamada K; Yamada Y; Masuda H; Yamagami M; Yoneda M; Takada O; Sawada S; Kitani T
Rinsho Ketsueki; 1992 Nov; 33(11):1666-72. PubMed ID: 1469781
[TBL] [Abstract][Full Text] [Related]
18. [Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent].
Dittel M; Haushofer A; Spiel R; Halbmayer WM; Prachar H; Fischer M; Mlczoch J
Z Kardiol; 1995 Jan; 84(1):22-9. PubMed ID: 7863710
[TBL] [Abstract][Full Text] [Related]
19. Course of thrombin activation markers in patients implanted with Palmaz-Schatz stents: first experiences with a post-interventional anticoagulation regimen.
Haushofer A; Halbmayer WM; Dittel M; Prachar H; Mlczoch J; Fischer M
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):697-706. PubMed ID: 7865675
[TBL] [Abstract][Full Text] [Related]
20. Coagulation activation and reactive fibrinolysis in patients receiving oral anticoagulation after total hip or knee replacement.
van Wersch JW; de Vries-Hanje JC; Oosterbos C
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):605-8. PubMed ID: 7841318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
